April 23, 2026 | Tokyo, Japan
From April 21 to 23, 2026, NanoMicro participated in CPHI JAPAN 2026 at Tokyo Big Sight, joining pharmaceutical and biopharmaceutical professionals from around the world.
With 802 exhibitors and more than 33,000 visitors from 36 countries and regions, CPHI JAPAN provided an important platform for industry leaders to exchange insights and explore new opportunities across Japan’s pharmaceutical supply chain.

Connecting with a High-Standard Pharmaceutical Market
Japan is one of Asia’s most established pharmaceutical markets, with high expectations for product quality, consistency, regulatory compliance and technical support.
At the exhibition, NanoMicro engaged with pharmaceutical companies, biotechnology companies and industry partners to better understand the evolving requirements of the Japanese market. These conversations reinforced the importance of combining high-performance chromatography media with reliable quality assurance and localized technical support.
Showcasing Integrated Separation and Purification Solutions
Under the theme “Your Allies in Separation, Purification and Analysis,” NanoMicro presented chromatography media and related technologies covering a broad range of applications, including protein purification, ion exchange, size exclusion, hydrophobic interaction and reversed-phase chromatography.
Together with solutions from SEPURE, NANOCHROM and FULI, the exhibition also highlighted NanoMicro’s broader capabilities across separation, purification and analysis.
Building Long-Term Partnerships
For NanoMicro, participation in CPHI JAPAN was not simply about showcasing products. It was an opportunity to build closer relationships with customers and partners and to gain deeper insight into one of Asia’s most demanding pharmaceutical markets.
The experience also reinforced NanoMicro’s commitment to developing localized application support and international customer service capabilities.

Looking Ahead
As NanoMicro continues to expand globally, Japan remains an important market for strengthening its international capabilities.
By combining advanced chromatography technologies with application expertise, consistent product quality and responsive customer support, NanoMicro looks forward to building deeper partnerships with customers in Japan and around the world.
NanoMicro remains committed to being a trusted partner in separation, purification and analysis for the global pharmaceutical and biopharmaceutical industry.
Related Reading
-
World's First! NanoMicro Leads Release of International Standard for Silica Chromatography Resins -
New Product Launch | NanoMicro NW Super S Series Ushers Protein Fine Separation into the Era of High Resolution -
Upgraded Launch! NMab Titan HC High-Capacity Protein A Resin Redefines Purification Efficiency